In the present study, studying the potential role of LCN2 in CCl4-treated ob/ob mice can provide valuable insights into the pathophysiology of fatty liver and subsequent progression to hepatic fibrosis and can help to identify potential therapeutic targets. This evidence concerns the gene LCN2 and Hepatic fibrosis.